| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 04/29/2009 | EP2051722A2 Method for treating diabetic vascular complications |
| 04/29/2009 | EP2051716A1 Induction of weight loss and the selective inhibition of ptp1b |
| 04/29/2009 | EP2051583A2 Compositions and methods for treating vascular, autoimmune, and inflammatory diseases |
| 04/29/2009 | EP1765311A4 Reducing nephropathy with inhibitors of soluble epoxide hydrolase and epoxyeicosanoids |
| 04/29/2009 | EP1758905B1 8-[3-amino-piperidin-1-yl]-xanthine, the production thereof and the use in the form of a ddp-iv inhibitor |
| 04/29/2009 | EP1687631B1 Methods for identifying compounds involved in the phosphoinositide-mediated signalling and use thereof in the manufacture of medicaments |
| 04/29/2009 | EP1485347B1 Hif hydroxylase inhibitors for use in the treatment of anaemia |
| 04/29/2009 | EP1454136B1 Methods and means for influencing intracellular communication and intracellular organelle transport |
| 04/29/2009 | EP1450806B1 Use of sulfonamide derivatives in the treatment of obesity or for the reduction of food intake |
| 04/29/2009 | EP1446125B1 Thieno-(1,3)-oxazin-4-ones with lipase inhibiting activity |
| 04/29/2009 | EP1383540B1 Methods and pharmaceutical compositions for healing wounds |
| 04/29/2009 | EP1267914B1 Use of lysosomal acid lipase for treating atherosclerosis and related diseases |
| 04/29/2009 | EP1218509B1 Fibroblast growth factor-like polypeptides |
| 04/29/2009 | CN101421278A Condensed imidazole derivatives as aldosterone synthase inhibitors |
| 04/29/2009 | CN101421260A Chromen-2-one derivatives |
| 04/29/2009 | CN101421256A Thiadiazolidinone inhibitors of ptpase |
| 04/29/2009 | CN101421255A Novel acetyl-coa carboxylase (acc) inhibitors and their use in diabetes, obesity and metabolic syndrome |
| 04/29/2009 | CN101421251A 4,5-diphenyl-pyrimidinyl-amino substituted carboxylic acids, method for the production and use thereof as medicaments |
| 04/29/2009 | CN101421249A 4,5-diphenyl-pyrimidinyl-oxy or -mercapto substituted carboxylic acids, method for the production and use thereof as medicaments |
| 04/29/2009 | CN101421248A 4,5-diphenyl-pyrimidinyl substituted carboxylic acids, method for the production and use thereof as medicaments |
| 04/29/2009 | CN101421235A 5-amido-2-carboxamide indoles |
| 04/29/2009 | CN101421229A Improved crystalline material |
| 04/29/2009 | CN101420943A Chewing composition containing coenzyme Q10 |
| 04/29/2009 | CN101420867A Novel nutraceutical compositions |
| 04/29/2009 | CN101418270A High density culture method of lactobacillus casei Zhang, method for preparing freeze-dried powder by using the same and obtained freeze-dried powder and uses thereof |
| 04/29/2009 | CN101418001A Dipeptidase-IV inhibitor sulfonyl urea derivates |
| 04/29/2009 | CN101418000A DPP-IV inhibitor derivates containing benzofuran sulfonyl ureas |
| 04/29/2009 | CN101417999A Piperazines derivates, preparation method thereof and application thereof in medicine |
| 04/29/2009 | CN101417988A Biguanide piperazines dipeptidyl peptidase IV inhibitor |
| 04/29/2009 | CN101417987A DPP-IV inhibitor with sulfonamide formyl piperazine structure |
| 04/29/2009 | CN101417969A Cinnamoyl pyrrolidine derivates and preparation method and use thereof |
| 04/29/2009 | CN101417964A Use of compounds for the elevation of pyruvate dehydrogenase activity |
| 04/29/2009 | CN101417124A Biocompatible material and process for manufacturing the same |
| 04/29/2009 | CN101417114A Traditional Chinese medicine for treating hypertension and high blood-fat |
| 04/29/2009 | CN101417094A Traditional Chinese medicine preparation for adjusting blood sugar |
| 04/29/2009 | CN101417089A Multiple-effect invert microelement powder |
| 04/29/2009 | CN101417088A Chinese patent medicine for treating diabetic cataract |
| 04/29/2009 | CN101417077A Compound buckwheat flower and leaf flavones preparation for controlling diabetes and complicating disease thereof and preparation method thereof |
| 04/29/2009 | CN101417063A Oral traditional Chinese medicine for treating obesity |
| 04/29/2009 | CN101417058A Traditional Chinese medicine combination for treating obesity |
| 04/29/2009 | CN101417056A Traditional Chinese medicine decoction for treating obesity |
| 04/29/2009 | CN101417034A Medicine composition for preventing the birth defect and improving the memory |
| 04/29/2009 | CN101417030A Chinese patent medicine for curing diabetes |
| 04/29/2009 | CN101417015A Medicine composition for preventing the birth defect and improving the memory |
| 04/29/2009 | CN101417012A Medicine composition for preventing the birth defect and improving the memory |
| 04/29/2009 | CN101417011A Medicine composition for preventing the birth defect and improving the memory |
| 04/29/2009 | CN101417010A Medicine composition for preventing the birth defect and improving the memory |
| 04/29/2009 | CN101417007A Traditional Chinese medicine formulation for treating non-insulin dependent diabetes mellitus and preparation method and use thereof |
| 04/29/2009 | CN101416999A Traditional Chinese medicine formulation for treating cerebrovascular disease |
| 04/29/2009 | CN101416994A Medicine composition for prenatal and postnatal care and preventing the birth defect and improving the memory |
| 04/29/2009 | CN101416992A Beggarticks dispersion tablets and preparation method thereof |
| 04/29/2009 | CN101416991A Traditional Chinese medicine preparation for treating cerebrovascular disease and preparation technique thereof |
| 04/29/2009 | CN101416984A Bone-nourishing calcium tablet |
| 04/29/2009 | CN101416975A Plant extract composition capable of treating or preventing diabetes |
| 04/29/2009 | CN101416971A Use of betulinic acid in preparing glycosidase inhibitor medicine |
| 04/29/2009 | CN101416970A Use of arjunolic acid in preparing glycosidase inhibitor |
| 04/29/2009 | CN101416951A Preparation method of cmellia sponin controlled release tablets |
| 04/29/2009 | CN101416950A Preparation method of cmellia sponin controlled release tablets |
| 04/29/2009 | CN101416944A Sodium ferulic acid nano micelle preparation and preparation method thereof |
| 04/29/2009 | CN101416934A Calcium gluconate gel |
| 04/29/2009 | CN101416737A Candy suitable of diabetic |
| 04/29/2009 | CN101416725A Function food capable of adjusting blood sugar using apple pectin as main component and preparation method thereof |
| 04/29/2009 | CN101416724A Function food capable of adjusting blood fat and reducing cholesterol using apple pectin as main component and preparation method thereof |
| 04/29/2009 | CN100482686C Treatment for diabetes |
| 04/29/2009 | CN100482684C Cytokine protein family |
| 04/29/2009 | CN100482665C Pyrazolo 1,5-a pyrimidine derivatives |
| 04/29/2009 | CN100482664C 1,5-disubstituted-3,4-dihydro-1H-pyrimido [4,5-D] pyrimidi-2-one compounds and their use in treating CSBP/P38 kinase mediated diseases |
| 04/29/2009 | CN100482638C N-acylaminobenzene dervatives as selective monoamine oxidase b inhibitors |
| 04/29/2009 | CN100482280C Highly compressible ethylcellulose for tableting |
| 04/29/2009 | CN100482278C Micro-cluster liquids and methods of making and using them |
| 04/29/2009 | CN100482276C Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| 04/29/2009 | CN100482267C Preparation for diabetes and its making method |
| 04/29/2009 | CN100482248C Application of 'Kidney Benefiting Injection' in the process for preparing medicine to treat diabetic nephropathy |
| 04/29/2009 | CN100482246C Chinese herb medical preparation for treating diabetes and its preparation method |
| 04/29/2009 | CN100482243C Application of olecranone bean extraction in preparation of food for preventing and treating obesity and type II diabetes |
| 04/29/2009 | CN100482237C Polysaccharid glucoside Chinese medicinal oral preparation and its making method thereof |
| 04/29/2009 | CN100482234C Stibene-glucoside oral liquid and its production method |
| 04/29/2009 | CN100482233C Compositions and methods for treating amyloidosis |
| 04/29/2009 | CN100482219C Novel compounds, pharmaceutical compositions containing same, and methods of use for same |
| 04/29/2009 | CN100482216C Use of hydroxide-releasing agents as skin permeation enhancers |
| 04/29/2009 | CN100482213C Monascus pellet and its preparing method |
| 04/29/2009 | CN100482109C Nutrition liquid for regulating physiological funnction |
| 04/29/2009 | CN100482104C Process for preparing lactic acid bacteria oral liquor |
| 04/28/2009 | US7524975 Peroxisome proliferator activated receptor ligand and process for producing the same |
| 04/28/2009 | US7524969 Cardiovascular disorders; anticancer agents; antidiabetic agents; dietetics |
| 04/28/2009 | US7524957 Compounds effecting glucokinase |
| 04/28/2009 | US7524949 Prevention or therapy of cardiovascular complications |
| 04/28/2009 | US7524873 Substituted N-phenylmethyl ethanamines; N-((6-(methyloxy)-4'-(trifluoromethyl)-1,1'-biphenyl-3-yl)methyl)-1-(1-naphthalenyl)ethanamine; parathyroid hormone inhibitors; antisecretory agents; osteoporosis |
| 04/28/2009 | US7524858 Substituted pyrroline kinase inhibitors |
| 04/28/2009 | US7524852 Bicyclic pyrimidine derivatives |
| 04/28/2009 | US7524847 Inhibit Dipeptidyl peptidase-IV; 7-(2-Butynyl)-3-methyl-3,7-dihydropurine-2,6-dione; suppress degradation of Glucagon-Like Peptide-1; enhance action of incretin; facilitate insulin secretion from pancreatic beta -cells due to glucose stimulus; postchallenge hyperglycemia, improved oral glucose tolerance |
| 04/28/2009 | US7524817 Osteogenic protein/bone morphogenetic proteins of eukaryotic origin |
| 04/28/2009 | US7524815 Bovine or colostrum; milk, yogurt, curd, cheese, fermented milks, milk-based fermented products, ice creams, fermented cereal-based products, milk-based powders, infant formula, pet food; Osteoporosis, Paget's Disease, hypercalcemia, bone loss from arthritis, necrosis, or periodontal disease |
| 04/28/2009 | US7524649 Chimeric polypeptide having a modified binding domain of growth hormone linked to a receptor binding domain of growth hormone receptor; treating giantism; acromegaly; cancer diabetic retinopathy; diabetic nephropathy, diabetic complications and any disease of growth hormone excess |
| 04/28/2009 | US7524517 Methods and compositions for P2X receptor calcium entry channels and other calcium entry mechanisms |
| 04/28/2009 | CA2507465C Phenyl substituted piperidine compounds for use as ppar activators |
| 04/28/2009 | CA2472954C Aza-arylpiperazines |
| 04/28/2009 | CA2346396C 4,5-dihydro-isoxazole derivatives and their pharmaceutical use |
| 04/28/2009 | CA2336783C Novel 2,3,3a,4,9,9a hexahydro-8-hydroxy-1h-benz[f]indoles, a method for the production thereof, and their use as medicaments |
| 04/28/2009 | CA2334761C Composition comprising .beta.-hydroxy-.beta.-methylbutyric acid and at least one amino acid and methods of use |